Cowen Reiterates Outperform Rating on Cellebrite (CLBT) After Hosting CFO for Meeting
Tweet Send to a Friend
Cowen analyst Shaul Eyal reiterated an Outperform rating and $10.00 price target on Cellebrite (NASDAQ: CLBT) following the management meeting.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
